Author:
Rummukainen Petri,Tarkkonen Kati,Al Majidi Rana,Puolakkainen Tero,Nieminen-Pihala Vappu,Valensisi Cristina,Saastamoinen Lauri,Hawkins David,Heino Terhi J.,Ivaska Kaisa K.,Kiviranta Riku
Reference49 articles.
1. Genetics and epigenetics of bone remodeling and metabolic bone diseases;Oton-Gonzalez;Int. J. Mol. Sci. [Internet].,2022
2. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation;Lee;Mol. Endocrinol.,2006
3. Paino F, La Noce M, Tirino V, Naddeo P, Desiderio V, Pirozzi G, De Rosa A, et al. Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement. Stem Cells Int. 2014 Jan;32(1):279–89. Available from: https://pubmed.ncbi.nlm.nih.gov/24105979.
4. Razidlo DF, Whitney TJ, Casper ME, McGee-Lawrence ME, Stensgard BA, Li X, Secreto FJ, et al. Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS One [Internet]. 2010 Jul 9;5(7):e11492–e11492. Available from: https://pubmed.ncbi.nlm.nih.gov/20628553.
5. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3;Kang;EMBO J [Internet].,2005